BARKER DAVID L 4
4 · Singular Genomics Systems, Inc. · Filed Jul 11, 2022
Insider Transaction Report
Form 4
BARKER DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2022-07-07$0.63/sh+60,000$37,800→ 60,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-07-07−60,000→ 0 totalExercise: $0.63Exp: 2029-12-16→ Common Stock (60,000 underlying)
Holdings
- 1,000,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The Reporting Person is the trustee of The Barker/Loring Trust and has voting and dispositive power with respect to these shares.
- [F2]Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares are fully vested and may be exercised at any time.